Company intelligence / Profile preview

Generis

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

The CARA Platform is an AI-powered, highly configurable enterprise content and information management system used by large and mid-sized life sciences companies for document/data/business process management and compliance across clinical, regulatory, quality, and manufacturing functions. The platform is now available in a "Starter Package" for emerging biotech and mid-sized pharma organizations, with customers expanding rapidly globally as they replace legacy systems. Recent innovations include CARA AI for enhanced search and document intelligence.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Generis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Generis.

Explore the full profile